Clearstead Advisors’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$173 Buy
+11
New +$141 ﹤0.01% 3237
2025
Q4
– Sell
-850
Closed -$8.06K – 2869
2025
Q3
$8.06K Sell
850
-15
-2% -$126 ﹤0.01% 1987
2025
Q2
$6.45K Buy
+865
New +$5.37K ﹤0.01% 2035
2022
Q2
– Sell
-16
Closed -$1K – 1315
2022
Q1
$1K Buy
+16
New +$605 ﹤0.01% 1274
2021
Q4
– Sell
-323
Closed -$21K – 1311
2021
Q3
$21K Buy
+323
New +$19.9K ﹤0.01% 798

Other funds holding CYRX

Clearstead Advisors's CYRX Position: Q2 2026 in Review

Clearstead Advisors opened a new position in CryoPort (CYRX) in Q2 2026: 11 shares worth $173. The stake represents ﹤0.01% of the portfolio and ranks #3237 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in CYRX as recently as Q3 2025.

Clearstead Advisors first reported a position in CYRX in Q3 2021 and has held it in 5 quarters since. The position peaked at $21K in Q3 2021. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Clearstead Advisors held 11 shares of CryoPort worth $173 as of Q2 2026.
  • CryoPort was a new Clearstead Advisors position in Q2 2026.
  • CryoPort made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3237 holding.
  • Clearstead Advisors first reported a position in CryoPort in Q3 2021 and has held it in 5 quarters since.
  • Clearstead Advisors's CryoPort position peaked at $21K in Q3 2021.
  • 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.